Warangal, India

Raja Gopal Penumandla

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raja Gopal Penumandla. Retrieved from https://idiyas.com/inventor/raja-gopal-penumandla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raja Gopal Penumandla: Innovator in Pharmaceutical Chemistry

Introduction

Raja Gopal Penumandla is a notable inventor based in Warangal, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the preparation of important compounds.

Latest Patents

Raja Gopal Penumandla holds a patent for the "Process for preparation of eribulin and intermediates thereof." This patent relates to the preparation of tetrahydrofuran compounds and tetrahydropyran compounds, which are essential intermediates for the synthesis of halichondrin B analogues, such as Eribulin and its pharmaceutically acceptable salts. He has 1 patent to his name.

Career Highlights

Raja Gopal Penumandla is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its innovative approaches to drug development. His work at Dr. Reddy's has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Raja has collaborated with talented professionals, including Kumar Sarvesh and Debjit Basu. These collaborations have enhanced his research and contributed to the advancement of pharmaceutical sciences.

Conclusion

Raja Gopal Penumandla's contributions to pharmaceutical chemistry and his innovative patent work exemplify the impact of dedicated inventors in the field. His ongoing efforts continue to shape the future of drug development and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…